StonvexLoading…
StonvexCore line items from DK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.65B | $10.72B | $2.89B | $2.76B |
Operating Income | $-179.30M | $301.00M | $295.70M | $-33.50M |
Net Income | $-201.30M | $-22.80M | $178.00M | $-106.40M |
EPS (Diluted) | $-3.34 | $-0.38 | $-1.66 | $-4.55 |
Total Assets | $7.57B | $6.85B | $7.08B | $7.07B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $624.10M | $625.80M | $630.90M | $615.50M |
Free Cash Flow OCF − CapEx | $273.40M | $6.30M | $-376.50M | $-312.50M |
Shares Outstanding | 60.26M | 60.70M | 60.93M | 61.31M |